People · Operator

Robert K. More

Named in public records as an officer, director or promoter · active 2010–2010 · Other Health Care

1
Companies
1
Filings
$19.6M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Carticept Medical IncOther Health CareSeries A$19.6M$193.0M2010
Operator network

Robert K. More at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brian K. Halak · 5 companies · 1 sharedBrian K. HalakRobert J. More · 4 companies · 1 sharedRobert J. MorePeter J. Pizzo III · 3 companies · 1 sharedPeter J. Pizzo IIIRyan D. Drant · 3 companies · 1 sharedRyan D. DrantBarbara D. Boyan · 2 companies · 1 sharedBarbara D. BoyanDeborah J. Moore · 2 companies · 1 sharedDeborah J. MooreRichard B. Knostman · 2 companies · 1 sharedRichard B. Knostm…Robert R. Singer · 2 companies · 1 sharedRobert R. SingerTimothy J. Patrick · 2 companies · 1 sharedTimothy J. PatrickBarbara D. Boyan, Ph.D. · 1 companies · 1 sharedBarbara D. Boyan,…Barry J. Hassett · 1 companies · 1 sharedBarry J. HassettBrian K. Halak, Ph.D. · 1 companies · 1 sharedBrian K. Halak, P…Kevin J. Goodwin · 1 companies · 1 sharedKevin J. GoodwinSteven P. Walsh · 1 companies · 1 sharedSteven P. WalshCarticept Medical Inc · $19.6M raisedCarticept Medical IncRobert K. MoreRM
Robert K. More Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Robert K. More on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian K. Halak15
Robert J. More14
Ryan D. Drant13
Peter J. Pizzo III13
Richard B. Knostman12
Robert R. Singer12
Barbara D. Boyan12
Deborah J. Moore12
Timothy J. Patrick12
Barry J. Hassett11
Brian K. Halak, Ph.D.11
Kevin J. Goodwin11
Barbara D. Boyan, Ph.D.11
Steven P. Walsh11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.